Skip to main content
Erschienen in: Cancer Causes & Control 8/2014

01.08.2014 | Original paper

Different time trends by gender for the incidence of Hodgkin’s lymphoma among young adults in the USA: a birth cohort phenomenon

verfasst von: Cairong Zhu, Bryan A. Bassig, Kunchong Shi, Peter Boyle, Huan Guo, Tongzhang Zheng

Erschienen in: Cancer Causes & Control | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Hodgkin’s lymphoma (HL) is one of the most common cancers among young adults. We investigated the time trends for HL among the 20–44 age group in the USA by gender to identify the potential factors accounting for the incidence trends.

Methods

Using data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results program for 1973–2010, we conducted age–period–cohort modeling to evaluate birth cohort patterns on incidence trends of HL over time.

Results

For all races combined, the age-adjusted incidence patterns were similar to that of whites. The birth cohort patterns for whites and all races were similar, but the patterns differed according to gender. Specifically, except for the 1970–1975 birth cohort, all other birth cohorts showed an increasing birth cohort trend for females. Conversely, there was a decreasing cohort trend in males beginning in the 1960 birth cohort regardless of the assumptions of the period effect.

Conclusion

The established risk factors for HL can seemingly not explain the gender disparities of the cohort pattern, which necessitates further analytical epidemiological studies to explore the risk factors for this disease with respect to potential differences by gender and by histological subtype.
Literatur
1.
Zurück zum Zitat Ries LAG (2007) Cancer survival among adults: U.S. SEER program 1988–2001 patient and tumor characteristics. SEER survival monograph. U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda, MD Ries LAG (2007) Cancer survival among adults: U.S. SEER program 1988–2001 patient and tumor characteristics. SEER survival monograph. U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda, MD
2.
Zurück zum Zitat Ariad S, Lipshitz I, Benharroch D, Gopas J, Barchana M (2009) A sharp rise in the incidence of Hodgkin’s lymphoma in young adults in Israel. Isr Med Assoc J 11(8):453–455PubMed Ariad S, Lipshitz I, Benharroch D, Gopas J, Barchana M (2009) A sharp rise in the incidence of Hodgkin’s lymphoma in young adults in Israel. Isr Med Assoc J 11(8):453–455PubMed
3.
Zurück zum Zitat Hjalgrim H, Seow A, Rostgaard K, Friborg J (2008) Changing patterns of Hodgkin lymphoma incidence in Singapore. Int J Cancer 123(3):716–719PubMedCrossRef Hjalgrim H, Seow A, Rostgaard K, Friborg J (2008) Changing patterns of Hodgkin lymphoma incidence in Singapore. Int J Cancer 123(3):716–719PubMedCrossRef
4.
Zurück zum Zitat Hjalgrim H, Askling J, Pukkala E, Hansen S, Munksgaard L, Frisch M (2001) Incidence of Hodgkin’s disease in Nordic countries. Lancet 358(9278):297–298PubMedCrossRef Hjalgrim H, Askling J, Pukkala E, Hansen S, Munksgaard L, Frisch M (2001) Incidence of Hodgkin’s disease in Nordic countries. Lancet 358(9278):297–298PubMedCrossRef
5.
Zurück zum Zitat Liu S, Semenciw R, Waters C, Wen SW, Mao Y (2000) Time trends and sex patterns in Hodgkin’s disease incidence in Canada, 1970–1995. Can J Public Health 91(3):188–192PubMed Liu S, Semenciw R, Waters C, Wen SW, Mao Y (2000) Time trends and sex patterns in Hodgkin’s disease incidence in Canada, 1970–1995. Can J Public Health 91(3):188–192PubMed
6.
Zurück zum Zitat Chen YT, Zheng T, Chou MC, Boyle P, Holford TR (1997) The increase of Hodgkin’s disease incidence among young adults: experience in Connecticut, 1935–1992. Cancer 79(11):2209–2218PubMedCrossRef Chen YT, Zheng T, Chou MC, Boyle P, Holford TR (1997) The increase of Hodgkin’s disease incidence among young adults: experience in Connecticut, 1935–1992. Cancer 79(11):2209–2218PubMedCrossRef
7.
Zurück zum Zitat Evens AM, Antillon M, Aschebrook-Kilfoy B, Chiu BC (2012) Racial disparities in Hodgkin’s lymphoma: a comprehensive population-based analysis. Ann Oncol 23(8):2128–2137PubMedCrossRef Evens AM, Antillon M, Aschebrook-Kilfoy B, Chiu BC (2012) Racial disparities in Hodgkin’s lymphoma: a comprehensive population-based analysis. Ann Oncol 23(8):2128–2137PubMedCrossRef
9.
Zurück zum Zitat Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 107(1):265–276PubMedCentralPubMedCrossRef Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 107(1):265–276PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Holford TR (2003) Monitoring the health of populations statistical principles and methods for public health surveillance. Oxford Univerity Press, Oxford Holford TR (2003) Monitoring the health of populations statistical principles and methods for public health surveillance. Oxford Univerity Press, Oxford
11.
Zurück zum Zitat Cartwright RA, Watkins G (2004) Epidemiology of Hodgkin’s disease: a review. Hematol Oncol 22(1):11–26PubMedCrossRef Cartwright RA, Watkins G (2004) Epidemiology of Hodgkin’s disease: a review. Hematol Oncol 22(1):11–26PubMedCrossRef
12.
Zurück zum Zitat Glaser SL, Clarke CA, Nugent RA, Stearns CB, Dorfman RF (2003) Reproductive factors in Hodgkin’s disease in women. Am J Epidemiol 158(6):553–563PubMedCrossRef Glaser SL, Clarke CA, Nugent RA, Stearns CB, Dorfman RF (2003) Reproductive factors in Hodgkin’s disease in women. Am J Epidemiol 158(6):553–563PubMedCrossRef
13.
Zurück zum Zitat Morton LM, Wang SS, Richesson DA, Schatzkin A, Hollenbeck AR, Lacey JV (2009) Reproductive factors, exogenous hormone use and risk of lymphoid neoplasms among women in the National Institutes of Health-AARP Diet and Health Study Cohort. Int J Cancer 124(11):2737–2743PubMedCentralPubMedCrossRef Morton LM, Wang SS, Richesson DA, Schatzkin A, Hollenbeck AR, Lacey JV (2009) Reproductive factors, exogenous hormone use and risk of lymphoid neoplasms among women in the National Institutes of Health-AARP Diet and Health Study Cohort. Int J Cancer 124(11):2737–2743PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Miligi L, Costantini AS, Benvenuti A, Kriebel D, Bolejack V, Tumino R, Ramazzotti V, Rodella S, Stagnaro E, Crosignani P, Amadori D, Mirabelli D, Sommani L, Belletti I, Troschel L, Romeo L, Miceli G, Tozzi GA, Mendico I, Vineis P (2006) Occupational exposure to solvents and the risk of lymphomas. Epidemiology 17(5):552–561PubMedCrossRef Miligi L, Costantini AS, Benvenuti A, Kriebel D, Bolejack V, Tumino R, Ramazzotti V, Rodella S, Stagnaro E, Crosignani P, Amadori D, Mirabelli D, Sommani L, Belletti I, Troschel L, Romeo L, Miceli G, Tozzi GA, Mendico I, Vineis P (2006) Occupational exposure to solvents and the risk of lymphomas. Epidemiology 17(5):552–561PubMedCrossRef
15.
Zurück zum Zitat Zahm SH, Hoover RN, Fraumeni JF Jr (1995) Hodgkin’s disease and parity. Int J Cancer 62(3):362–363PubMedCrossRef Zahm SH, Hoover RN, Fraumeni JF Jr (1995) Hodgkin’s disease and parity. Int J Cancer 62(3):362–363PubMedCrossRef
16.
Zurück zum Zitat Glaser SL (1994) Reproductive factors in Hodgkin’s disease in women: a review. Am J Epidemiol 139(3):237–246PubMed Glaser SL (1994) Reproductive factors in Hodgkin’s disease in women: a review. Am J Epidemiol 139(3):237–246PubMed
18.
Zurück zum Zitat Crawford DH, Swerdlow AJ, Higgins C, McAulay K, Harrison N, Williams H, Britton K, Macsween KF (2002) Sexual history and Epstein-Barr virus infection. J Infect Dis 186(6):731–736PubMedCrossRef Crawford DH, Swerdlow AJ, Higgins C, McAulay K, Harrison N, Williams H, Britton K, Macsween KF (2002) Sexual history and Epstein-Barr virus infection. J Infect Dis 186(6):731–736PubMedCrossRef
19.
Zurück zum Zitat Chang ET, Zheng T, Lennette ET, Weir EG, Borowitz M, Mann RB, Spiegelman D, Mueller NE (2004) Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma. J Infect Dis 189(12):2271–2281PubMedCrossRef Chang ET, Zheng T, Lennette ET, Weir EG, Borowitz M, Mann RB, Spiegelman D, Mueller NE (2004) Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma. J Infect Dis 189(12):2271–2281PubMedCrossRef
20.
Zurück zum Zitat Carbone A, Gloghini A, Serraino D, Spina M (2009) HIV-associated Hodgkin lymphoma. Curr Opin HIV AIDS 4(1):3–10PubMedCrossRef Carbone A, Gloghini A, Serraino D, Spina M (2009) HIV-associated Hodgkin lymphoma. Curr Opin HIV AIDS 4(1):3–10PubMedCrossRef
21.
Zurück zum Zitat Glaser SL, Clarke CA, Gulley ML, Craig FE, DiGiuseppe JA, Dorfman RF, Mann RB, Ambinder RF (2003) Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988–1998. Cancer 98(2):300–309PubMedCrossRef Glaser SL, Clarke CA, Gulley ML, Craig FE, DiGiuseppe JA, Dorfman RF, Mann RB, Ambinder RF (2003) Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988–1998. Cancer 98(2):300–309PubMedCrossRef
23.
Zurück zum Zitat Maggioncalda A, Malik N, Shenoy P, Smith M, Sinha R, Flowers CR (2011) Clinical, molecular, and environmental risk factors for Hodgkin lymphoma. Adv Hematol 2011:736261PubMedCentralPubMedCrossRef Maggioncalda A, Malik N, Shenoy P, Smith M, Sinha R, Flowers CR (2011) Clinical, molecular, and environmental risk factors for Hodgkin lymphoma. Adv Hematol 2011:736261PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Sergentanis TN, Kanavidis P, Michelakos T, Petridou ET (2013) Cigarette smoking and risk of lymphoma in adults: a comprehensive meta-analysis on Hodgkin and non-Hodgkin disease. Eur J Cancer Prev 22(2):131–150PubMedCrossRef Sergentanis TN, Kanavidis P, Michelakos T, Petridou ET (2013) Cigarette smoking and risk of lymphoma in adults: a comprehensive meta-analysis on Hodgkin and non-Hodgkin disease. Eur J Cancer Prev 22(2):131–150PubMedCrossRef
25.
Zurück zum Zitat Frieden TR (2011) Forward: CDC health disparities and inequalities report—United States, 2011. MMWR Surveill Summ 60 Suppl:1–2 Frieden TR (2011) Forward: CDC health disparities and inequalities report—United States, 2011. MMWR Surveill Summ 60 Suppl:1–2
26.
Zurück zum Zitat King B, Dube S, Kaufmann R, Shaw L, Pechacek T (2011) Vital signs: current cigarette smoking among adults aged >=18 years-United States, 2005–2010 (Reprinted from MMWR, vol 60, pg 1207–1212, 2011). JAMA 306(17):1857–1860 King B, Dube S, Kaufmann R, Shaw L, Pechacek T (2011) Vital signs: current cigarette smoking among adults aged >=18 years-United States, 2005–2010 (Reprinted from MMWR, vol 60, pg 1207–1212, 2011). JAMA 306(17):1857–1860
27.
Zurück zum Zitat Larsson SC, Wolk A (2011) Body mass index and risk of non-Hodgkin’s and Hodgkin’s lymphoma: a meta-analysis of prospective studies. Eur J Cancer 47(16):2422–2430PubMedCrossRef Larsson SC, Wolk A (2011) Body mass index and risk of non-Hodgkin’s and Hodgkin’s lymphoma: a meta-analysis of prospective studies. Eur J Cancer 47(16):2422–2430PubMedCrossRef
28.
Zurück zum Zitat Li Q, Chang ET, Bassig BA, Dai M, Qin Q, Gao Y, Zhang Y, Zheng T (2013) Body size and risk of Hodgkin’s lymphoma by age and gender: a population-based case–control study in Connecticut and Massachusetts. Cancer Causes Control 24(2):287–295PubMedCentralPubMedCrossRef Li Q, Chang ET, Bassig BA, Dai M, Qin Q, Gao Y, Zhang Y, Zheng T (2013) Body size and risk of Hodgkin’s lymphoma by age and gender: a population-based case–control study in Connecticut and Massachusetts. Cancer Causes Control 24(2):287–295PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303(3):235–241PubMedCrossRef Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303(3):235–241PubMedCrossRef
30.
Zurück zum Zitat Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307(5):491–497PubMedCrossRef Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307(5):491–497PubMedCrossRef
31.
Zurück zum Zitat Chang ET, Zheng T, Weir EG, Borowitz M, Mann RB, Spiegelman D, Mueller NE (2004) Aspirin and the risk of Hodgkin’s lymphoma in a population-based case–control study. J Natl Cancer Inst 96(4):305–315PubMedCrossRef Chang ET, Zheng T, Weir EG, Borowitz M, Mann RB, Spiegelman D, Mueller NE (2004) Aspirin and the risk of Hodgkin’s lymphoma in a population-based case–control study. J Natl Cancer Inst 96(4):305–315PubMedCrossRef
32.
Zurück zum Zitat Chang ET, Froslev T, Sorensen HT, Pedersen L (2011) A nationwide study of aspirin, other non-steroidal anti-inflammatory drugs, and Hodgkin lymphoma risk in Denmark. Br J Cancer 105(11):1776–1782PubMedCentralPubMedCrossRef Chang ET, Froslev T, Sorensen HT, Pedersen L (2011) A nationwide study of aspirin, other non-steroidal anti-inflammatory drugs, and Hodgkin lymphoma risk in Denmark. Br J Cancer 105(11):1776–1782PubMedCentralPubMedCrossRef
33.
Zurück zum Zitat Sanchez DR, Diez Roux AV, Michos ED, Blumenthal RS, Schreiner PJ, Burke GL, Watson K (2011) Comparison of the racial/ethnic prevalence of regular aspirin use for the primary prevention of coronary heart disease from the multi-ethnic study of atherosclerosis. Am J Cardiol 107(1):41–46PubMedCentralPubMedCrossRef Sanchez DR, Diez Roux AV, Michos ED, Blumenthal RS, Schreiner PJ, Burke GL, Watson K (2011) Comparison of the racial/ethnic prevalence of regular aspirin use for the primary prevention of coronary heart disease from the multi-ethnic study of atherosclerosis. Am J Cardiol 107(1):41–46PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Opotowsky AR, McWilliams JM, Cannon CP (2007) Gender differences in aspirin use among adults with coronary heart disease in the United States. J Gen Intern Med 22(1):55–61PubMedCentralPubMedCrossRef Opotowsky AR, McWilliams JM, Cannon CP (2007) Gender differences in aspirin use among adults with coronary heart disease in the United States. J Gen Intern Med 22(1):55–61PubMedCentralPubMedCrossRef
35.
Zurück zum Zitat Costas L, Casabonne D, Benavente Y, Becker N, Boffetta P, Brennan P, Cocco P, Foretova L, Maynadie M, Staines A, Kane E, Nieters A, de Sanjose S (2012) Reproductive factors and lymphoid neoplasms in Europe: findings from the EpiLymph case–control study. Cancer Causes Control 23(1):195–206PubMedCrossRef Costas L, Casabonne D, Benavente Y, Becker N, Boffetta P, Brennan P, Cocco P, Foretova L, Maynadie M, Staines A, Kane E, Nieters A, de Sanjose S (2012) Reproductive factors and lymphoid neoplasms in Europe: findings from the EpiLymph case–control study. Cancer Causes Control 23(1):195–206PubMedCrossRef
36.
Zurück zum Zitat Kravdal O, Hansen S (1993) Hodgkin’s disease: the protective effect of childbearing. Int J Cancer 55(6):909–914PubMedCrossRef Kravdal O, Hansen S (1993) Hodgkin’s disease: the protective effect of childbearing. Int J Cancer 55(6):909–914PubMedCrossRef
37.
Zurück zum Zitat Mathews TJ, Hamilton BE (2002) Mean age of mother, 1970–2000. Natl Vital Stat Rep 51(1):1–13PubMed Mathews TJ, Hamilton BE (2002) Mean age of mother, 1970–2000. Natl Vital Stat Rep 51(1):1–13PubMed
38.
Zurück zum Zitat Glaser SL, Swartz WG (1990) Time trends in Hodgkin’s disease incidence: the role of diagnostic accuracy. Cancer 66(10):2196–2204PubMedCrossRef Glaser SL, Swartz WG (1990) Time trends in Hodgkin’s disease incidence: the role of diagnostic accuracy. Cancer 66(10):2196–2204PubMedCrossRef
Metadaten
Titel
Different time trends by gender for the incidence of Hodgkin’s lymphoma among young adults in the USA: a birth cohort phenomenon
verfasst von
Cairong Zhu
Bryan A. Bassig
Kunchong Shi
Peter Boyle
Huan Guo
Tongzhang Zheng
Publikationsdatum
01.08.2014
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 8/2014
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-014-0391-5

Weitere Artikel der Ausgabe 8/2014

Cancer Causes & Control 8/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.